Rejuvant™ Safety and Biomarker Study

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

February 7, 2020

Primary Completion Date

February 14, 2022

Study Completion Date

February 14, 2022

Conditions
Aging Well
Interventions
DIETARY_SUPPLEMENT

Rejuvant

"Rejuvant tablets are sustained release tablets that release the active ingredients over 8-12 hours. Both product tablets are 0.500 round and 0.290 thick.~AKG and AKG salts are grandfathered as GRAS compounds because these compounds were supplements prior to the Dietary Supplement Health and Education Act of 1994 (DSHEA). AKG and AKG salts are currently sold in the United States as supplements.~The other components of the tablets are Vitamin A for the men's product and Vitamin D3 for the women's product. Vitamin A and Vitamin D are GRAS compounds per the FDA"

DIETARY_SUPPLEMENT

Placebo

Matching placebo tablets are composed of Cellulose, Carnauba wax and/or rice bran wax (to match the specs), stearic acid, magnesium stearate and silica.

Trial Locations (1)

46202

Indiana University School of Medicine, Indianapolis

All Listed Sponsors
lead

Ponce De Leon Health

INDUSTRY

NCT04821401 - Rejuvant™ Safety and Biomarker Study | Biotech Hunter | Biotech Hunter